Identification of Single Biomolecules Could Soon Be Even Faster
|
By LabMedica International staff writers Posted on 08 Feb 2016 |
Scientists have developed a breakthrough new method that may soon enable the capture of individual biological molecules 1,000 times faster, leading to more efficient research and diagnostic detection for important medical conditions.
Gathering and identifying molecules for analysis can be done by passing molecules in solution through a nanopore and detecting the change in electric current the molecules create. The problem with this technique, “nanopore sensing,” is that it is usually diffusion-limited, and so relies on molecules drifting close to the nanopore before being captured.
Now, a team led by researchers at Imperial College London (London, UK) in collaboration with colleagues at University of Minnesota (Minneapolis – St. Paul; MN; USA) have demonstrated a technique to attract molecules towards the nanopore, making the process up to 1,000 times more efficient.
“By pulling molecules towards the detector instead of relying purely on diffusion, we can access a much larger volume, and by doing so can detect the same number of molecules from a much smaller concentration,” said senior author Dr. Joshua Edel from Imperial, “What might currently take 5 hours to analyze could be done in a couple of minutes with our new method.”
The technique, “single molecule dielectrophoretic trapping,” will also allow for analysis of very dilute samples. Capability to analyze molecules in low-concentration samples could be particularly important when looking for evidence of epigenetic modifications such as DNA methylation. The team tested their method with DNA molecules, but said it could be modified to detect a wide range of medically important molecules, from proteins to whole cells.
The technique uses an electrically-charged nano-pipette that exerts an electrical attraction force on the molecule that draws it close to the pipette tip, the nanopore. The shape and minute size of the tip, less than 50 nanometres, enables detection of single molecules.
Detecting and analyzing each molecule individually also avoids the problem of averaged results that obscure rare, but possibly important, events. “We can now capture needle-in-a-haystack events,” said coauthors Dr. Aleksandar Ivanov and Dr. Kevin Freedman of Imperial. “The huge increase in efficiency brought about by this technique paves the way for high-speed and high-throughput detection of rare events in ultra-dilute samples.” The team has filed a patent for their invention and expect that it will have application implications in the near future.
The study, by Freedman KJ et al., was published 2016, in the journal Nature Communications.
Related Links:
Imperial College London
University of Minnesota
Gathering and identifying molecules for analysis can be done by passing molecules in solution through a nanopore and detecting the change in electric current the molecules create. The problem with this technique, “nanopore sensing,” is that it is usually diffusion-limited, and so relies on molecules drifting close to the nanopore before being captured.
Now, a team led by researchers at Imperial College London (London, UK) in collaboration with colleagues at University of Minnesota (Minneapolis – St. Paul; MN; USA) have demonstrated a technique to attract molecules towards the nanopore, making the process up to 1,000 times more efficient.
“By pulling molecules towards the detector instead of relying purely on diffusion, we can access a much larger volume, and by doing so can detect the same number of molecules from a much smaller concentration,” said senior author Dr. Joshua Edel from Imperial, “What might currently take 5 hours to analyze could be done in a couple of minutes with our new method.”
The technique, “single molecule dielectrophoretic trapping,” will also allow for analysis of very dilute samples. Capability to analyze molecules in low-concentration samples could be particularly important when looking for evidence of epigenetic modifications such as DNA methylation. The team tested their method with DNA molecules, but said it could be modified to detect a wide range of medically important molecules, from proteins to whole cells.
The technique uses an electrically-charged nano-pipette that exerts an electrical attraction force on the molecule that draws it close to the pipette tip, the nanopore. The shape and minute size of the tip, less than 50 nanometres, enables detection of single molecules.
Detecting and analyzing each molecule individually also avoids the problem of averaged results that obscure rare, but possibly important, events. “We can now capture needle-in-a-haystack events,” said coauthors Dr. Aleksandar Ivanov and Dr. Kevin Freedman of Imperial. “The huge increase in efficiency brought about by this technique paves the way for high-speed and high-throughput detection of rare events in ultra-dilute samples.” The team has filed a patent for their invention and expect that it will have application implications in the near future.
The study, by Freedman KJ et al., was published 2016, in the journal Nature Communications.
Related Links:
Imperial College London
University of Minnesota
Latest Molecular Diagnostics News
- Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia
- Blood Test Could Help Detect Gallbladder Cancer Earlier
- New Blood Test Score Detects Hidden Alcohol-Related Liver Disease
- New Blood Test Predicts Who Will Most Likely Live Longer
- Genetic Test Predicts Radiation Therapy Risk for Prostate Cancer Patients
- Genetic Test Aids Early Detection and Improved Treatment for Cancers
- New Genome Sequencing Technique Measures Epstein-Barr Virus in Blood
- Blood Test Boosts Early Detection of Brain Cancer
- Molecular Monitoring Approach Helps Bladder Cancer Patients Avoid Surgery
- Genetic Tests to Speed Diagnosis of Lymphatic Disorders
- Changes In Lymphatic Vessels Can Aid Early Identification of Aggressive Oral Cancer
- New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids
- New CSF Liquid Biopsy Assay Reveals Genomic Insights for CNS Tumors
- AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy
- Group A Strep Molecular Test Delivers Definitive Results at POC in 15 Minutes
- Rapid Molecular Test Identifies Sepsis Patients Most Likely to Have Positive Blood Cultures
Channels
Clinical Chemistry
view channelNew Blood Test Index Offers Earlier Detection of Liver Scarring
Metabolic fatty liver disease is highly prevalent and often silent, yet it can progress to fibrosis, cirrhosis, and liver failure. Current first-line blood test scores frequently return indeterminate results,... Read more
Electronic Nose Smells Early Signs of Ovarian Cancer in Blood
Ovarian cancer is often diagnosed at a late stage because its symptoms are vague and resemble those of more common conditions. Unlike breast cancer, there is currently no reliable screening method, and... Read moreMolecular Diagnostics
view channel
Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia
Acute myeloid leukemia (AML) is a rare but aggressive blood cancer in which relapse after allogeneic stem cell transplant remains a major clinical challenge, particularly for patients with NPM1-mutated disease.... Read more
Blood Test Could Help Detect Gallbladder Cancer Earlier
Gallbladder cancer is one of the deadliest gastrointestinal cancers because it is often diagnosed at an advanced stage when treatment options are limited. Early symptoms are minimal, and current screening... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Hidden Gut Viruses Linked to Colorectal Cancer Risk
Colorectal cancer (CRC) remains a leading cause of cancer mortality in many Western countries, and existing risk-stratification approaches leave substantial room for improvement. Although age, diet, and... Read more
Three-Test Panel Launched for Detection of Liver Fluke Infections
Parasitic liver fluke infections remain endemic in parts of Asia, where transmission commonly occurs through consumption of raw freshwater fish or aquatic plants. Chronic infection is a well-established... Read morePathology
view channel
Molecular Imaging to Reduce Need for Melanoma Biopsies
Melanoma is the deadliest form of skin cancer and accounts for the vast majority of skin cancer-related deaths. Because early melanomas can closely resemble benign moles, clinicians often rely on visual... Read more
Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency
Urine testing is a critical, non-invasive diagnostic tool used to detect conditions such as pregnancy, urinary tract infections, metabolic disorders, cancer, and kidney disease. However, contaminated or... Read moreIndustry
view channel
Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss
Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more







 Analyzer.jpg)